|
Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system and potentiating their natural painkilling and antidepressant properties.
|